Abstract

Studies were previously conducted in our laboratory on the influence of n‐alkanols, 1‐alkyl‐2‐pyrrolidones, N,N‐dimethlyalkanamides, and 1,2‐alkanediols as skin permeation enhancers on the transport of a model permeant, corticosterone (CS). The experiments were conducted with hairless mouse skin (HMS) in a side‐by‐side, two‐chamber diffusion cell, with enhancer present in an aqueous buffer in both chambers. The purpose of the present study was to extend these studies and investigate in greater detail the hypothesis that a suitable semipolar organic phase may mimic the microenvironment of the site of enhancer action, and that the enhancer partitioning tendency into this organic phase may be used to predict the enhancer potency. CS flux enhancement along the lipoidal pathway of HMS stratum corneum was determined with the 1‐alkyl‐2‐azacycloheptanones, 1‐alkyl‐2‐piperidinones, 1,2‐dihydroxypropyl decanoate, 1,2‐dihydroxypropyl octanoate, n‐alkyl‐β‐D‐glucopyranosides, 2‐(1‐alkyl)‐2‐methyl‐1,3‐dioxolanes, 1,2,3‐nonanetriol, and trans‐hydroxyproline‐N‐decanamide‐C‐ethylamide as enhancers. Enhancement factors (E values) were calculated from the permeability coefficient and solubility data over a range of E values. Comparisons of the enhancer potencies for all studied homologous series and the carbon number of the n‐alkyl group revealed a nearly semilogarithmic linear relationship with a slope of ∼0.55, which is consistent with the hydrophobic effect. Moreover, comparisons of the enhancer potencies of all the enhancers with the n‐hexanol–phosphate buffered saline (PBS), n‐octanol–PBS, n‐decanol–PBS, and n‐hexane–PBS partition coefficients showed very good correlations for the n‐alkanol solvents but not for n‐hexane. This result supports the interpretation that the enhancer potency is directly related to the ability of the enhancer molecule to translocate to a site of action via its free energy of transfer from the bulk aqueous phase to a semipolar microenvironment in the stratum corneum lipid lamella that is well mimicked by water‐saturated n‐alkanols. © 2003 Wiley‐Liss, Inc. and the American Pharmaceutical Association J Pharm Sci 92:1305–1322, 2003

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.